Template:Hypertrophic cardiomyopathy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 35: Line 35:
!
!
Pathophysiology
Pathophysiology
|-
!
|- bgcolor="Pink"
!
:[[Hypertrophic cardiomyopathy genetics|Genetics]]
:[[Hypertrophic cardiomyopathy genetics|Genetics]]
|-
!
|- bgcolor="Pink"
!
:[[Hypertrophic cardiomyopathy histopathology|Histopathology]]
|-
!
|- bgcolor="Pink"
!
:[[Hypertrophic cardiomyopathy gross pathology|Gross Pathology]]
|-
!
|- bgcolor="Pink"
!
:[[Hypertrophic cardiomyopathy anatomic abnormalities|Anatomic Abnormalities]]
|-
!
|- bgcolor="Pink"
!
:[[Hypertrophic cardiomyopathy outflow obstruction|Outflow Obstruction]]
:[[Hypertrophic cardiomyopathy outflow obstruction|Outflow Obstruction]]
|-
!
|- bgcolor="Pink"
!
:[[Hypertrophic cardiomyopathy diastolic dysfunction|Diastolic Dysfunction]]
:[[Hypertrophic cardiomyopathy diastolic dysfunction|Diastolic Dysfunction]]
|-
!
|- bgcolor="Pink"
!
:[[Hypertrophic cardiomyopathy ischemia|Ischemia]]
:[[Hypertrophic cardiomyopathy ischemia|Ischemia]]
|-
!
|- bgcolor="Pink"
!
:[[Hypertrophic cardiomyopathy arrhythmogenesis|Arrhythmogenesis]]
:[[Hypertrophic cardiomyopathy arrhythmogenesis|Arrhythmogenesis]]
:[[Hypertrophic cardiomyopathy anatomic abnormalities|Anatomic Abnormalities]]
:[[Hypertrophic cardiomyopathy histopathology|Histopathology]]
:[[Hypertrophic cardiomyopathy gross pathology|Gross Pathology]]
|-
|-
!
!
Line 106: Line 66:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[Hypertrophic cardiomyopathy risk factors for sudden death|Risk Factors For Sudden Death]]
[[Hypertrophic cardiomyopathy risk factors for sudden death|Risk Factors For Sudden Death]]
|-
|-
!
!
Line 184: Line 144:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Hypertrophic cardiomyopathy medical therapy|Medical Therapy]]
Medical Therapy
:[[Hypertrophic cardiomyopathy treatment strategy|Treatment Strategy]]
:[[Hypertrophic cardiomyopathy medical treatment#Simple Supportive Measures|Supportive Therapy]]
:[[Hypertrophic cardiomyopathy medical treatment#Pharmacotherapy|Pharmacotherapy]]
:[[Hypertrophic cardiomyopathy medical treatment#2011 ACCF/AHA Guideline Recommendations: Pharmacologic Management in Symptomatic Patients|Guidelines]]  
|-
|-
!
!
Line 190: Line 154:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Hypertrophic cardiomyopathy activities and circumstances to avoid|Activities/Circumstances to Avoid]]
Invasive Therapy
:[[Hypertrophic cardiomyopathy alcohol septal ablation|Alcohol Septal Ablation]]
:[[Hypertrophic cardiomyopathy septal myectomy|Septal Myectomy]]
:[[Hypertrophic cardiomyopathy ventricular pacing|Ventricular Pacing]]
:[[Hypertrophic cardiomyopathy automatic implantable cardiac defibrillator placement|Automatic Implantable Cardiac Defibrillator (AICD) Placement]]
:[[Hypertrophic cardiomyopathy invasive therapy guidelines|Guidelines]]  
|-
|-
!
!
Line 196: Line 165:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Hypertrophic cardiomyopathy management during childhood|Management During Childhood]]
[[Hypertrophic cardiomyopathy surgery#Cardiac transplantation|Cardiac transplantation]]
|-
|-
!
!
Line 202: Line 171:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Special Scenario
:[[Hypertrophic cardiomyopathy management during childhood|Management During Childhood]]
:[[Hypertrophic cardiomyopathy activities and circumstances to avoid|Activities/Circumstances to Avoid]]
:[[Hypertrophic cardiomyopathy management during pregnancy|Management During Pregnancy]]
:[[Hypertrophic cardiomyopathy management during pregnancy|Management During Pregnancy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Hypertrophic cardiomyopathy surgery|Surgery]]
|-
|-
!
!

Revision as of 17:11, 11 February 2012